Literature DB >> 19584677

Cytoplasmic inheritance of transplantation antigens in animals produced by nuclear transfer.

John S Hanekamp1, Masayoshi Okumi, Aseda Tena, Scott Arn, Kazuhiko Yamada, David H Sachs.   

Abstract

BACKGROUND: Nuclear transfer has been used as a means of selectively modifying the mammalian genome. One possible consequence of this technology is that the oocytes used in nuclear transfer may provide additional antigens by cytoplasmic inheritance of maternally derived, mitochondrial DNA (mtDNA). These studies examine the potential consequences of such inheritance in a large animal transplantation model.
METHODS: Renal transplants were performed between major histocompatibility complex (MHC)-identical animals differing only in the source of their maternally derived cytoplasmic DNA, using a protocol, which uniformly leads to tolerance within standard MHC-inbred lines. In an attempt to correlate transplant results with a putative marker for disparities in cytoplasmically inherited minor histocompatibility antigens, we examined one hypervariable region of mtDNA, designated hypervariable region 1 (HV1).
RESULTS: The mtDNA sequence of the HV1 region was found to be invariant among MGH miniature swine of different haplotypes, despite 25 years of selective breeding of the sublines of this colony. In contrast, swine derived by nuclear transfer into outbred oocytes differed in the HV1 region sequence from each other and from MGH swine. Renal transplants from standard, inbred MGH swine to their MHC-identical knockout counterparts derived from outbred oocytes were rejected within 2 weeks, whereas transplants in the reverse direction were accepted for over 30 days.
CONCLUSIONS: The HV1 sequence of mtDNA may serve as a marker for the level of diversity of mtDNA. These transplant data are consistent with the existence of mtDNA-encoded mitochondrial minor antigens with a level of diversity that can influence the outcome of renal transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584677      PMCID: PMC2936509          DOI: 10.1097/TP.0b013e3181a9ed5b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  20 in total

1.  The ancestry of Brazilian mtDNA lineages.

Authors:  J Alves-Silva; M da Silva Santos; P E Guimarães; A C Ferreira; H J Bandelt; S D Pena; V F Prado
Journal:  Am J Hum Genet       Date:  2000-06-28       Impact factor: 11.025

2.  Skin-specific alloantigens in miniature swine.

Authors:  Y Fuchimoto; Z L Gleit; C A Huang; H Kitamura; M L Schwarze; M T Menard; K Mawulawde; J C Madsen; D H Sachs
Journal:  Transplantation       Date:  2001-07-15       Impact factor: 4.939

3.  Histocompatible miniature swine: an inbred large-animal model.

Authors:  Joshua D Mezrich; Gary W Haller; J Scott Arn; Stuart L Houser; Joren C Madsen; David H Sachs
Journal:  Transplantation       Date:  2003-03-27       Impact factor: 4.939

4.  Transplantation in miniature swine. I. Fixation of the major histocompatibility complex.

Authors:  D H Sachs; G Leight; J Cone; S Schwarz; L Stuart; S Rosenberg
Journal:  Transplantation       Date:  1976-12       Impact factor: 4.939

Review 5.  The role of maternal effects in animal breeding. II. Mitochondria and animal inheritance.

Authors:  R P Wagner
Journal:  J Anim Sci       Date:  1972-12       Impact factor: 3.159

6.  The complete mitochondrial DNA sequence of the pig (Sus scrofa).

Authors:  B M Ursing; U Arnason
Journal:  J Mol Evol       Date:  1998-09       Impact factor: 2.395

7.  Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.

Authors:  Liangxue Lai; Donna Kolber-Simonds; Kwang-Wook Park; Hee-Tae Cheong; Julia L Greenstein; Gi-Sun Im; Melissa Samuel; Aaron Bonk; August Rieke; Billy N Day; Clifton N Murphy; David B Carter; Robert J Hawley; Randall S Prather
Journal:  Science       Date:  2002-01-03       Impact factor: 47.728

8.  Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine.

Authors:  L R Pennington; J K Lunney; D H Sachs
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

9.  Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age.

Authors:  Francis J Miller; Franklin L Rosenfeldt; Chunfang Zhang; Anthony W Linnane; Phillip Nagley
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

10.  Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations.

Authors:  Donna Kolber-Simonds; Liangxue Lai; Steven R Watt; Maria Denaro; Scott Arn; Monica L Augenstein; Jeffery Betthauser; David B Carter; Julia L Greenstein; Yanhong Hao; Gi-Sun Im; Zhonghua Liu; Greg D Mell; Clifton N Murphy; Kwang-Wook Park; August Rieke; David J J Ryan; David H Sachs; Erik J Forsberg; Randall S Prather; Robert J Hawley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

View more
  3 in total

1.  The innate immune system in host mice targets cells with allogenic mitochondrial DNA.

Authors:  Kaori Ishikawa; Noriko Toyama-Sorimachi; Kazuto Nakada; Mami Morimoto; Hirotake Imanishi; Mariko Yoshizaki; Shigemi Sasawatari; Mamoru Niikura; Keizo Takenaga; Hiromichi Yonekawa; Jun-Ichi Hayashi
Journal:  J Exp Med       Date:  2010-10-11       Impact factor: 14.307

Review 2.  Impaired mitochondrial metabolism and mammary carcinogenesis.

Authors:  Nagendra Yadava; Sallie S Schneider; D Joseph Jerry; Chul Kim
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-12-27       Impact factor: 2.673

3.  MHC-matched induced pluripotent stem cells can attenuate cellular and humoral immune responses but are still susceptible to innate immunity in pigs.

Authors:  Yoshihisa Mizukami; Tomoyuki Abe; Hiroaki Shibata; Yukitoshi Makimura; Shuh-hei Fujishiro; Kimihide Yanase; Shuji Hishikawa; Eiji Kobayashi; Yutaka Hanazono
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.